Moderna says new data supports its COVID vaccine for kids 6 to 11
Published
Moderna says a study in kids 6 to 11 found two doses of the company's COVID-19 vaccine given 28 days apart produced a strong antibody response.
Full ArticlePublished
Moderna says a study in kids 6 to 11 found two doses of the company's COVID-19 vaccine given 28 days apart produced a strong antibody response.
Full Articlehttps://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
Watch VideoThe Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer's COVID-19..